Oct 27 (Reuters) – GSK expects to nearly double the number of cancer medicines it is testing in clinical trials next year, the Wall Street Journal reported on Tuesday, citing an interview with a scientist at the British drugmaker.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Harikrishnan Nair)
Comments